APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Valine

Valine is an amino acid necessary for human health. It is known as a branched chain amino acid (BCAA). Valine is responsible for encouraging normal human growth, repairing tissue, and regulating blood sugar.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Valine is an amino acid necessary for human health. It is known as a branched chain amino acid (BCAA). Valine is responsible for encouraging normal human growth, repairing tissue, and regulating blood sugar.

This report mainly covers the Valine product type L-Valine and D-Valine, Feed, food, and Medicine by application, while we can also offer any product survey report related to the Valine industry chain.

Selected research

Market Outlook & Growth Opportunities

Global Valine Market Outlook and Growth Opportunities 2026

Report ID 173374380421 December 2025196 pages

Choose your research edition.

Industry ResearchValine Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Valine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Valine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Valine Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

Valine is an amino acid necessary for human health. It is known as a branched chain amino acid (BCAA). Valine is responsible for encouraging normal human growth, repairing tissue, and regulating blood sugar.

This report mainly covers the Valine product type L-Valine and D-Valine, Feed, food, and Medicine by application, while we can also offer any product survey report related to the Valine industry chain.

At present, the Valine production market concentrates in USA, Europe, China, Japan. China is the largest production country of valine in the world in the past few years and it will keep the same position in the next few years. The China market took up about28.67% the global market.

Read the full market overview

This report provides an overview of the global Valine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valine market size, projected growth trends, production technologies, key applications, and end-use industries.

Valine Segment by Company

Ajinomoto

Kyowa Hakko

Evonik

CJ

Fufeng Group

Maidan Biology

Meihua Group

Sanxia Pharmaceutical

Tianjin Tianan

Wellman Bioscience

Jinghai Amino Acid

Bafeng Pharmaceutical

Jiahe Biotech

Luzhou Group

Jirong Pharmaceutical

Valine Segment by Type

L-Valine

D-Valine

Others

Valine Segment by Application

Feed

Food

Medicine

Other

Valine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Valine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valine significant trends, drivers, influence factors in global and regions.

6. To analyze Valine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valine industry.

Chapter 3: Detailed analysis of Valine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valine Industry Trends Table 2. Valine Industry Drivers Table 3. Valine Industry Opportunities and Challenges Table 4. Valine Industry Restraints Table 5. Global Valine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valine Revenue Share by Company (2021-2026) Table 7. Global Valine Sales Volume by Company (t) & (2021-2026) Table 8. Global Valine Sales Volume Share by Company (2021-2026) Table 9. Global Valine Average Price (USD/t) of Company (2021-2026) Table 10. Global Valine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valine Key Company Manufacturing Base & Headquarters Table 12. Global Valine Company, Product Type & Application Table 13. Global Valine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of L-Valine Table 18. Significant Companies of D-Valine Table 19. Significant Companies of Others Table 20. Global Valine Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Valine Sales Volume by Type (2021-2026) & (t) Table 22. Global Valine Sales Volume by Type (2027-2032) & (t) Table 23. Global Valine Sales Volume Share by Type (2021-2026) Table 24. Global Valine Sales Volume Share by Type (2027-2032) Table 25. Global Valine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Valine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Valine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Valine Sales Value Share by Type (2021-2026) Table 29. Global Valine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Feed Table 31. Significant Companies of Food Table 32. Significant Companies of Medicine Table 33. Significant Companies of Other Table 34. Global Valine Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Valine Sales Volume by Application (2021-2026) & (t) Table 36. Global Valine Sales Volume by Application (2027-2032) & (t) Table 37. Global Valine Sales Volume Share by Application (2021-2026) Table 38. Global Valine Sales Volume Share by Application (2027-2032) Table 39. Global Valine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Valine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Valine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Valine Sales Value Share by Application (2021-2026) Table 43. Global Valine Sales Value Share by Application (2027-2032) Table 44. Global Valine Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Valine Sales by Region (2021-2026) & (t) Table 46. Global Valine Sales Market Share by Region (2021-2026) Table 47. Global Valine Sales by Region (2027-2032) & (t) Table 48. Global Valine Sales Market Share by Region (2027-2032) Table 49. Global Valine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Valine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Valine Sales Value Share by Region (2021-2026) Table 52. Global Valine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Valine Sales Value Share by Region (2027-2032) Table 54. Global Valine Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Valine Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Valine Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Valine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Valine Sales by Country (2021-2026) & (t) Table 59. Global Valine Sales Market Share by Country (2021-2026) Table 60. Global Valine Sales by Country (2027-2032) & (t) Table 61. Global Valine Sales Market Share by Country (2027-2032) Table 62. Global Valine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Valine Sales Value Market Share by Country (2021-2026) Table 64. Global Valine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Valine Sales Value Market Share by Country (2027-2032) Table 66. Ajinomoto Company Information Table 67. Ajinomoto Business Overview Table 68. Ajinomoto Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Ajinomoto Valine Product Portfolio Table 70. Ajinomoto Recent Development Table 71. Kyowa Hakko Company Information Table 72. Kyowa Hakko Business Overview Table 73. Kyowa Hakko Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Kyowa Hakko Valine Product Portfolio Table 75. Kyowa Hakko Recent Development Table 76. Evonik Company Information Table 77. Evonik Business Overview Table 78. Evonik Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Evonik Valine Product Portfolio Table 80. Evonik Recent Development Table 81. CJ Company Information Table 82. CJ Business Overview Table 83. CJ Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. CJ Valine Product Portfolio Table 85. CJ Recent Development Table 86. Fufeng Group Company Information Table 87. Fufeng Group Business Overview Table 88. Fufeng Group Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Fufeng Group Valine Product Portfolio Table 90. Fufeng Group Recent Development Table 91. Maidan Biology Company Information Table 92. Maidan Biology Business Overview Table 93. Maidan Biology Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Maidan Biology Valine Product Portfolio Table 95. Maidan Biology Recent Development Table 96. Meihua Group Company Information Table 97. Meihua Group Business Overview Table 98. Meihua Group Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Meihua Group Valine Product Portfolio Table 100. Meihua Group Recent Development Table 101. Sanxia Pharmaceutical Company Information Table 102. Sanxia Pharmaceutical Business Overview Table 103. Sanxia Pharmaceutical Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Sanxia Pharmaceutical Valine Product Portfolio Table 105. Sanxia Pharmaceutical Recent Development Table 106. Tianjin Tianan Company Information Table 107. Tianjin Tianan Business Overview Table 108. Tianjin Tianan Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Tianjin Tianan Valine Product Portfolio Table 110. Tianjin Tianan Recent Development Table 111. Wellman Bioscience Company Information Table 112. Wellman Bioscience Business Overview Table 113. Wellman Bioscience Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Wellman Bioscience Valine Product Portfolio Table 115. Wellman Bioscience Recent Development Table 116. Jinghai Amino Acid Company Information Table 117. Jinghai Amino Acid Business Overview Table 118. Jinghai Amino Acid Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Jinghai Amino Acid Valine Product Portfolio Table 120. Jinghai Amino Acid Recent Development Table 121. Bafeng Pharmaceutical Company Information Table 122. Bafeng Pharmaceutical Business Overview Table 123. Bafeng Pharmaceutical Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Bafeng Pharmaceutical Valine Product Portfolio Table 125. Bafeng Pharmaceutical Recent Development Table 126. Jiahe Biotech Company Information Table 127. Jiahe Biotech Business Overview Table 128. Jiahe Biotech Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Jiahe Biotech Valine Product Portfolio Table 130. Jiahe Biotech Recent Development Table 131. Luzhou Group Company Information Table 132. Luzhou Group Business Overview Table 133. Luzhou Group Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. Luzhou Group Valine Product Portfolio Table 135. Luzhou Group Recent Development Table 136. Jirong Pharmaceutical Company Information Table 137. Jirong Pharmaceutical Business Overview Table 138. Jirong Pharmaceutical Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. Jirong Pharmaceutical Valine Product Portfolio Table 140. Jirong Pharmaceutical Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Valine Distributors List Table 144. Valine Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Valine Product Image Figure 2. Global Valine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valine Sales (2021-2032) & (t) Figure 5. Global Valine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Valine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. L-Valine Image Figure 10. D-Valine Image Figure 11. Others Image Figure 12. Global Valine Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Valine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Valine Sales Volume Share by Type (2021-2032) Figure 15. Global Valine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Valine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Valine Sales Value Share by Type (2021-2032) Figure 18. Feed Image Figure 19. Food Image Figure 20. Medicine Image Figure 21. Other Image Figure 22. Global Valine Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Valine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Valine Sales Volume Share by Application (2021-2032) Figure 25. Global Valine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Valine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Valine Sales Value Share by Application (2021-2032) Figure 28. Global Valine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Valine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Valine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Valine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Valine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Valine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Valine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Valine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Valine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Valine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Valine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • L-Valine
  • D-Valine
  • Others
Applications
  • Feed
  • Food
  • Medicine
  • Other
Companies covered
  • Ajinomoto
  • Kyowa Hakko
  • Evonik
  • CJ
  • Fufeng Group
  • Maidan Biology
  • Meihua Group
  • Sanxia Pharmaceutical
  • Tianjin Tianan
  • Wellman Bioscience
  • Jinghai Amino Acid
  • Bafeng Pharmaceutical
  • Jiahe Biotech
  • Luzhou Group
  • Jirong Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valine Sales Value (2021-2032)
  4. 1.2.2 Global Valine Sales Volume (2021-2032)
  5. 1.2.3 Global Valine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valine Market Dynamics
  1. 2.1 Valine Industry Trends
  2. 2.2 Valine Industry Drivers
  3. 2.3 Valine Industry Opportunities and Challenges
  4. 2.4 Valine Industry Restraints
3 Valine Market by Company
  1. 3.1 Global Valine Company Revenue Ranking in 2025
  2. 3.2 Global Valine Revenue by Company (2021-2026)
  3. 3.3 Global Valine Sales Volume by Company (2021-2026)
  4. 3.4 Global Valine Average Price by Company (2021-2026)
  5. 3.5 Global Valine Company Ranking (2024-2026)
  6. 3.6 Global Valine Company Manufacturing Base and Headquarters
  7. 3.7 Global Valine Company Product Type and Application
  8. 3.8 Global Valine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valine Market by Type
  1. 4.1 Valine Type Introduction
  2. 4.1.1 L-Valine
  3. 4.1.2 D-Valine
  4. 4.1.3 Others
  5. 4.2 Global Valine Sales Volume by Type
  6. 4.2.1 Global Valine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Valine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Valine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Valine Sales Value by Type
  10. 4.3.1 Global Valine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Valine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Valine Sales Value Share by Type (2021-2032)
5 Valine Market by Application
  1. 5.1 Valine Application Introduction
  2. 5.1.1 Feed
  3. 5.1.2 Food
  4. 5.1.3 Medicine
  5. 5.1.4 Other
  6. 5.2 Global Valine Sales Volume by Application
  7. 5.2.1 Global Valine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Valine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Valine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Valine Sales Value by Application
  11. 5.3.1 Global Valine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Valine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Valine Sales Value Share by Application (2021-2032)
6 Valine Regional Sales and Value Analysis
  1. 6.1 Global Valine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valine Sales by Region (2021-2032)
  3. 6.2.1 Global Valine Sales by Region: 2021-2026
  4. 6.2.2 Global Valine Sales by Region (2027-2032)
  5. 6.3 Global Valine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valine Sales Value by Region (2027-2032)
  9. 6.5 Global Valine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valine Sales Value (2021-2032)
  12. 6.6.2 North America Valine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valine Sales Value (2021-2032)
  15. 6.7.2 Europe Valine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valine Sales Value (2021-2032)
  21. 6.9.2 South America Valine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valine Sales Value Share by Country, 2025 VS 2032
7 Valine Country-level Sales and Value Analysis
  1. 7.1 Global Valine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valine Sales by Country (2021-2032)
  4. 7.3.1 Global Valine Sales by Country (2021-2026)
  5. 7.3.2 Global Valine Sales by Country (2027-2032)
  6. 7.4 Global Valine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajinomoto
  2. 8.1.1 Ajinomoto Company Information
  3. 8.1.2 Ajinomoto Business Overview
  4. 8.1.3 Ajinomoto Valine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ajinomoto Valine Product Portfolio
  6. 8.1.5 Ajinomoto Recent Developments
  7. 8.2 Kyowa Hakko
  8. 8.2.1 Kyowa Hakko Company Information
  9. 8.2.2 Kyowa Hakko Business Overview
  10. 8.2.3 Kyowa Hakko Valine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kyowa Hakko Valine Product Portfolio
  12. 8.2.5 Kyowa Hakko Recent Developments
  13. 8.3 Evonik
  14. 8.3.1 Evonik Company Information
  15. 8.3.2 Evonik Business Overview
  16. 8.3.3 Evonik Valine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Evonik Valine Product Portfolio
  18. 8.3.5 Evonik Recent Developments
  19. 8.4 CJ
  20. 8.4.1 CJ Company Information
  21. 8.4.2 CJ Business Overview
  22. 8.4.3 CJ Valine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CJ Valine Product Portfolio
  24. 8.4.5 CJ Recent Developments
  25. 8.5 Fufeng Group
  26. 8.5.1 Fufeng Group Company Information
  27. 8.5.2 Fufeng Group Business Overview
  28. 8.5.3 Fufeng Group Valine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fufeng Group Valine Product Portfolio
  30. 8.5.5 Fufeng Group Recent Developments
  31. 8.6 Maidan Biology
  32. 8.6.1 Maidan Biology Company Information
  33. 8.6.2 Maidan Biology Business Overview
  34. 8.6.3 Maidan Biology Valine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Maidan Biology Valine Product Portfolio
  36. 8.6.5 Maidan Biology Recent Developments
  37. 8.7 Meihua Group
  38. 8.7.1 Meihua Group Company Information
  39. 8.7.2 Meihua Group Business Overview
  40. 8.7.3 Meihua Group Valine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Meihua Group Valine Product Portfolio
  42. 8.7.5 Meihua Group Recent Developments
  43. 8.8 Sanxia Pharmaceutical
  44. 8.8.1 Sanxia Pharmaceutical Company Information
  45. 8.8.2 Sanxia Pharmaceutical Business Overview
  46. 8.8.3 Sanxia Pharmaceutical Valine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sanxia Pharmaceutical Valine Product Portfolio
  48. 8.8.5 Sanxia Pharmaceutical Recent Developments
  49. 8.9 Tianjin Tianan
  50. 8.9.1 Tianjin Tianan Company Information
  51. 8.9.2 Tianjin Tianan Business Overview
  52. 8.9.3 Tianjin Tianan Valine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Tianjin Tianan Valine Product Portfolio
  54. 8.9.5 Tianjin Tianan Recent Developments
  55. 8.10 Wellman Bioscience
  56. 8.10.1 Wellman Bioscience Company Information
  57. 8.10.2 Wellman Bioscience Business Overview
  58. 8.10.3 Wellman Bioscience Valine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Wellman Bioscience Valine Product Portfolio
  60. 8.10.5 Wellman Bioscience Recent Developments
  61. 8.11 Jinghai Amino Acid
  62. 8.11.1 Jinghai Amino Acid Company Information
  63. 8.11.2 Jinghai Amino Acid Business Overview
  64. 8.11.3 Jinghai Amino Acid Valine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jinghai Amino Acid Valine Product Portfolio
  66. 8.11.5 Jinghai Amino Acid Recent Developments
  67. 8.12 Bafeng Pharmaceutical
  68. 8.12.1 Bafeng Pharmaceutical Company Information
  69. 8.12.2 Bafeng Pharmaceutical Business Overview
  70. 8.12.3 Bafeng Pharmaceutical Valine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bafeng Pharmaceutical Valine Product Portfolio
  72. 8.12.5 Bafeng Pharmaceutical Recent Developments
  73. 8.13 Jiahe Biotech
  74. 8.13.1 Jiahe Biotech Company Information
  75. 8.13.2 Jiahe Biotech Business Overview
  76. 8.13.3 Jiahe Biotech Valine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jiahe Biotech Valine Product Portfolio
  78. 8.13.5 Jiahe Biotech Recent Developments
  79. 8.14 Luzhou Group
  80. 8.14.1 Luzhou Group Company Information
  81. 8.14.2 Luzhou Group Business Overview
  82. 8.14.3 Luzhou Group Valine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Luzhou Group Valine Product Portfolio
  84. 8.14.5 Luzhou Group Recent Developments
  85. 8.15 Jirong Pharmaceutical
  86. 8.15.1 Jirong Pharmaceutical Company Information
  87. 8.15.2 Jirong Pharmaceutical Business Overview
  88. 8.15.3 Jirong Pharmaceutical Valine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Jirong Pharmaceutical Valine Product Portfolio
  90. 8.15.5 Jirong Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valine Value Chain Analysis
  2. 9.1.1 Valine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valine Sales Mode & Process
  6. 9.2 Valine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valine Distributors
  9. 9.2.3 Valine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst